These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33270171)

  • 1. Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.
    Selen A; Müllertz A; Kesisoglou F; Ho RJY; Cook JA; Dickinson PA; Flanagan T
    AAPS J; 2020 Dec; 23(1):7. PubMed ID: 33270171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.
    Selen A; Müllertz A; Kesisoglou F; Ho RJY; Cook JA; Dickinson PA; Flanagan T
    AAPS J; 2020 Jul; 22(5):97. PubMed ID: 32719954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid.
    Dickinson PA; Kesisoglou F; Flanagan T; Martinez MN; Mistry HB; Crison JR; Polli JE; Cruañes MT; Serajuddin ATM; Müllertz A; Cook JA; Selen A
    J Pharm Sci; 2016 Nov; 105(11):3243-3255. PubMed ID: 27659159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.
    Selen A; Dickinson PA; Müllertz A; Crison JR; Mistry HB; Cruañes MT; Martinez MN; Lennernäs H; Wigal TL; Swinney DC; Polli JE; Serajuddin ATM; Cook JA; Dressman JB
    J Pharm Sci; 2014 Nov; 103(11):3377-3397. PubMed ID: 25256402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approach.
    Charoo NA; Cristofoletti R; Kim SK
    Drug Dev Ind Pharm; 2017 Apr; 43(4):668-677. PubMed ID: 28032517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to: Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption.
    Eriksson J; Sjögren E; Lennernäs H; Thörn H
    AAPS J; 2020 Dec; 23(1):8. PubMed ID: 33294945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction to: Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective.
    Riedmaier AE; DeMent K; Huckle J; Bransford P; Stillhart C; Lloyd R; Alluri R; Basu S; Chen Y; Dhamankar V; Dodd S; Kulkarni P; Olivares-Morales A; Peng CC; Pepin X; Ren X; Tran T; Tistaert C; Heimbach T; Kesisoglou F; Wagner C; Parrott N
    AAPS J; 2020 Nov; 23(1):6. PubMed ID: 33244667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Incorporating Breastfeeding-Related Variability with Physiologically Based Pharmacokinetic Modeling to Predict Infant Exposure to Maternal Medication Through Breast Milk: a Workflow Applied to Lamotrigine.
    Yeung CHT; Ito S; Autmizguine J; Edginton AN
    AAPS J; 2021 Jun; 23(4):83. PubMed ID: 34114050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular ultraviolet radiation exposure of welders.
    Tenkate TD
    Scand J Work Environ Health; 2017 May; 43(3):287-288. PubMed ID: 28295119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified stakeholder participation assessment framework for design thinking in health innovation.
    Hendricks S; Conrad N; Douglas TS; Mutsvangwa T
    Healthc (Amst); 2018 Sep; 6(3):191-196. PubMed ID: 29960878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public risk perception of relaxation of transmissible spongiform encephalopathies (TSE) measures in Europe.
    Dressel K; Perazzini A; Ru G; Van Wassenhove W
    J Toxicol Environ Health A; 2011; 74(22-24):1636-49. PubMed ID: 22043919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annotation data about multi criteria assessment methods used in the agri-food research: The french national institute for agricultural research (INRA) experience.
    Gésan-Guiziou G; Alaphilippe A; Andro M; Aubin J; Bockstaller C; Botreau R; Buche P; Collet C; Darmon N; Delabuis M; Girard A; Grateau R; Kansou K; Martinet V; Membré JM; Sabbadin R; Soler LG; Thiollet-Scholtus M; Tonda A; Van-Der-Werf H
    Data Brief; 2019 Aug; 25():104204. PubMed ID: 31406900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated review of the correlation between critical thinking ability and clinical decision-making in nursing.
    Lee DS; Abdullah KL; Subramanian P; Bachmann RT; Ong SL
    J Clin Nurs; 2017 Dec; 26(23-24):4065-4079. PubMed ID: 28557238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authors' response: Letter to the Editor concerning OCRA as preferred method in ISO standards on biomechanical risk factors.
    Armstrong TJ; Burdorf A; Descatha A; Farioli A; Graf M; Horie S; Marras WS; Potvin JR; Rempel D; Spatari G; Takala EP; Verbeek J; Violante FS
    Scand J Work Environ Health; 2018 Jul; 44(4):439-440. PubMed ID: 29961082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Systems Thinking to train future leaders in global health.
    Paxton A; Frost LJ
    Glob Public Health; 2018 Sep; 13(9):1287-1295. PubMed ID: 28691572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.
    Nassar AE; Kamel AM; Clarimont C
    Drug Discov Today; 2004 Dec; 9(23):1020-8. PubMed ID: 15574318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5
    Feng H; Liu K; Shen X; Liang J; Wang C; Qiu W; Cheng X; Zhao R
    Cell Death Dis; 2020 Nov; 11(11):1006. PubMed ID: 33230188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.